This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential Essential cookies enable basic functions and are necessary for the website to function properly.

Analytics Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.

Marketing Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

Events Overview ENETS 2023 SNMMI 2023 SNMMI 2024 ITM Symposium on Actinium-225 Targeted Radionuclide Therapy at Theranostics World Congress ITM Precision Oncology Symposium 2022 ITM's Symposium at NuklearMedizin 2022 2nd ICPO Forum for Theranostics in Precision Oncology ITM's ESMO 2021 Industry Satellite Symposium ITM Precision Oncology Symposium 2021 COMPETE e-poster at AACR 2021

COMPETE e-poster at AACR 2021

ITM Presents Design for Ongoing Phase III COMPETE Trial with n.c.a. 177Lu-Edotreotide at AACR Annual Meeting 2021

Presentation information

Title: COMPETE Phase III Trial – Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide vs. Everolimus in Progressive GEP-NET

Abstract No: 5201

Session: Phase III Clinical Trials in Progress

Presenter: Mona M. Wahba, MD
Mona M. Wahba is available for questions and discussions via the chat box function of the AACR poster section and will respond within 24 hours. Meetings can also be requested using the AACR system.

The poster is available for Healthcare Professionals - please click here.